With increasing concerns about COVID-19 reinfection, Pfizer and the National Institutes of Health are discussing potential studies regarding a longer treatment period with the antiviral medication Paxlovid.
Individual Studies Suggest Pfizer’s Paxlovid May Treat Long COVID
'Herd Immunity', BioSpace, CDC, Clinical Trials, CNN, Coronavirus Cases, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Reinfections, Dr. Anthony Fauci (Director), Hong Kong, Hospitalized COVID-19 Patients, JAMA Network, Long COVID, National Institute of Allergy and Infectious Diseases (NIAID), Omicron (B.1.1.529) (South Africa), Paxlovid, Psychiatric Disorders, R&D, Reuters, Sinovac, Stanford UniversityAlthough research is being conducted on Long COVID or Long COVID-19, whose symptoms continue for weeks and months after initial infection, there are very few ongoing clinical trials on treatments. Anecdotally, there has been what appears to be a successful treatment for Long Covid using Pfizer’s antiviral regimen Paxlovid.
Omicron sub-variant BA.2 accounts for about 55% of COVID variants in U.S. – CDC
Asia, CDC, CDC Guidelines, Coronavirus surge, COVID-19 cases, Dr. Anthony Fauci (Director), Europe, National Institute of Allergy and Infectious Diseases (NIAID), Omicron (B.1.1.529) (South Africa), Omicron BA.2, United StatesThe U.S. national public health agency said on March 29 that the BA.2 sub-variant of Omicron was estimated to account for more than half the coronavirus variants in the country.
Top U.S. infectious disease official Dr. Anthony Fauci said on March 22 he would not be surprised to see an increase in COVID-19 cases in the United States, but he does not expect a major surge.
Pfizer Boss Earned $24.3 Million in 2021 and Other COVID-19 News
AstraZeneca, Business, Coronavirus Disease (COVID-19) Pandemic, COVID-19 cases, COVID-19 Vaccinations, Dr. Anthony Fauci (Director), Hospitalized COVID-19 Patients, JAMA, Johns Hopkins University School of Medicine, Omicron BA.2, Pfizer, R&D, Researchers, Salaries, TinnitusPfizer CEO Albert Bourla raked in $24.3 million in total compensation in 2021. In other news, tinnitus (ringing or buzzing in one or both ears) might be a side effect of COVID-19 vaccines.
COVID-19 Update: Benefit of 4th Booster Could be Modest, New White House Coordinator
Appointments, Babies, BNT162b2 (Pfizer and BioNTech), Coronavirus Disease 2019 (COVID-19), COVID-19 booster shots, COVID-19 shots, COVID-19 transmission, COVID-19 Vaccinations, COVID-19 Vaccines, Covid-19 Variants, Dr. Anthony Fauci (Director), Emergency Use Authorization (EUA), FDA, Moderna, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), National Institute of Allergy and Infectious Diseases (NIAID), Newborns, Omicron BA.2, People on the Move, Pfizer, White HouseWhile Moderna and Pfizer-BioNTech have submitted Emergency Use Authorization (EUA) requests for their COVID-19 vaccines, the data so far suggest the benefits of a fourth shot may be modest.
Pfizer Inc. and the company’s German partner BioNTech SE on March 15 filed an application with U.S. regulators seeking emergency use authorization for a second booster shot of their COVID-19 vaccine for people aged 65 and older.
White House readies roadmap for future COVID outbreaks, seeks funding
Antivirals, Business, Congress, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Antibody Tests, COVID-19 Deaths, Covid-19 Variants, Dr. Anthony Fauci (Director), Health Officials, Joe Biden, National Institute of Allergy and Infectious Diseases (NIAID), Outbreaks, Pandemics, Pharmacy, Reuters Analysis, SchoolsTop U.S. health officials on March 2 laid out a national blueprint to manage COVID-19 going forward, vowing to prepare for any new variant outbreaks without shutting down schools and businesses and calling for additional funding from Congress.
Top U.S. infectious disease expert Dr. Anthony Fauci said on February 16 that it is time for the United States to start inching back towards normality, despite remaining risks from COVID-19.
1 in 5 Americans Have had COVID-19, Veklury Approved in New Indication
BNT162b2 (Pfizer and BioNTech), Breakthrough COVID-19, CDC, Centers for Medicare and Medicaid Services (CMS), Coronavirus Disease (COVID-19) Pandemic, COVID-19 Infections, COVID-19 Vaccines, Dr. Anthony Fauci (Director), Expanded Approval, FBI, FDA/Regulatory, Kids, National Institute of Allergy and Infectious Diseases (NIAID), Omicron (B.1.1.529) (South Africa), Remdesivir, United StatesAt least 1 in 5 Americans have been infected with COVID-19. In other news, the U.S. Food and Drug Administration approved Gilead Sciences’ supplemental New Drug Application for Veklury (remdesivir) for adults and adolescents with COVID-19 who are not hospitalized but are at high risk of progression to severe COVID-19, hospitalization or death.